Laddar...

Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.

We have previously described a clinical isolate of Escherichia coli (Q2) that is highly resistant to fluoroquinolones (MIC of ciprofloxacin, 16 micrograms/ml) but susceptible to nalidixic acid (MIC of nalidixic acid, 4 micrograms/ml) (N. Moniot-Ville, J. Guibert, N. Moreau, J.F. Acar, E. Collatz, an...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Cambau, E, Bordon, F, Collatz, E, Gutmann, L
Materialtyp: Artigo
Språk:Inglês
Publicerad: 1993
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC187948/
https://ncbi.nlm.nih.gov/pubmed/8392306
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!